4518-v APP669-711

Code:
4518-v
Name:
APP669-711
Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val
(Trifluoroacetate Form)
(M.W. 4688.3) C210H325N57O61S2
A Factor of Plasma Biomarker for Cerebral Amyloid
Package Price(Yen)
Vial 0.5 mg 30,000

main

Purity:
≧90.0% (HPLC)
Storage:
-20 ℃

Solubility: 0.1% NH4OH or DMSO (1 mM)

more information

Category:
Biologically Active Peptides

reference

  1. N. Kaneko, R. Yamamoto, T. Sato, and K. Tanaka, Proc. Jpn. Acad. B, 90, 104 (2014). (Identification in plasma)
  2. N. Kaneko, A. Nakamura, Y. Washimi, T. Kato, T. Sakurai, Y. Arahata, M. Bundo, A. Takeda, S. Niida, K. Ito, K. Toba, K. Tanaka, and K. Yanagisawa, Proc. Jpn. Acad. B, 90, 353 (2014). (Correlation between APP669-711/Aβ1-42 in plasma and cerebral amyloid deposition)
  3. A. Nakamura, N. Kaneko, V.L. Villemagne, T. Kato, J. Doecke, V. Dore, C. Fowler, Q.X. Li, R. Martins, C. Rowe, T. Tomita, K. Matsuzaki, K. Ishii, K. Ishii, Y. Arahata, S. Iwamoto, K. Ito, K. Tanaka, C.L. Masters, and K. Yanagisawa, Nature(London), 554, 249 (2018). (APP669-711/Aβ1-42 in plasma as a biomarker for Alzheimer's disease)